Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Current World Health Organization guidelines recommend routine antibiotic prophylaxis for women with perineal tear 3rd and 4th degree but not for 2nd degree because of insufficient evidence of effectiveness. The investigators aimed to investigate whether antibiotic prophylaxis prevented maternal infection after the first and second perineal tear after vaginal birth.
The PATPET trial is a randomized, controlled trial done at tertiary hospital obstetric units in Israel. Women who had first and second-degree tear (or after episiotomy) after delivery at 37 weeks or greater gestation, with no indication for ongoing prescription of antibiotics in the post-partum period and no contraindications to prophylactic Cefamezin (cefazolin), were randomly assigned (1:1) to receive a single intravenous dose of prophylactic antibiotic or not.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prophylactic antibiotic treatment | Experimental | Will be given Cefamezin antibiotic within 6 hours of delivery |
|
| No intervention | No Intervention | Will not get antibiotic prophylactics |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cefazolin (Cefamezin) | Drug | Cefamezin 2 gr within 6 hour of delivery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with a fever after delivery | Maternal fever above 38 C (Celsius) | 6 weeks of delivery |
| Measure | Description | Time Frame |
|---|---|---|
| Way of delivery | Type of delivery- vacuum-assisted delivery vs. vaginally | 6 weeks of delivery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Delivery
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yair Daykan, Dr | Contact | +972542198231 | yair.dykan@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Gil Shechter, Dr | Meir Medical Center , Tel Aviv University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Meir Medical Center | Kfar Saba | 11125 | Israel |
Yes
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011645 | Puerperal Infection |
| ID | Term |
|---|---|
| D011251 | Pregnancy Complications, Infectious |
| D007239 | Infections |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
| ID | Term |
|---|---|
| D002437 | Cefazolin |
| ID | Term |
|---|---|
| D002511 | Cephalosporins |
| D047090 | beta-Lactams |
| D007769 | Lactams |
| D000577 | Amides |
| D009930 |
Not provided
Not provided
parturition
Not provided
Not provided
Not provided
Not provided
| D000091642 | Urogenital Diseases |
| D011644 | Puerperal Disorders |
| Organic Chemicals |
| D013843 | Thiazines |
| D013457 | Sulfur Compounds |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |